Lakefront Biotherapeutics NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GLPGF | BHVN | SLS | LEGN | IOVA | NKTR | |
|---|---|---|---|---|---|---|
| Market cap | 2.11B | 2.10B | 2.33B | 3.75B | 6.38B | 1.27B |
| P/E (TTM) | 3.0 | — | — | — | — | — |
| Forward P/E | — | -8.0 | -115.4 | 18.4 | -72.0 | -3.6 |
| Price/book | 0.6 | 171.4 | 16.9 | 3.0 | 8.7 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −4.48% | −20.18% | +494.85% | −39.52% | +509.96% | −40.51% |
| Today | 0.00% | −5.51% | +1.67% | +1.96% | −0.35% | −3.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GLPGF news ›Lakefront Biotherapeutics Discloses Bank of America Stake Cut Below 10% Threshold
Lakefront Biotherapeutics ( (LKFT) ) has issued an announcement. On October 8, 2026, Lakefront Biotherapeutics reported that it had received a transparency notification under Belgian disclosure rules from Bank of America Corporation. The…
Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation
Published on 08/24/2026 at 04:43 pm EDT - Modified on 08/24/2026 at 04:44 pm EDT A Lakefront Biotherapeutics treatment for the autoimmune disorder pemphigus received orphan drug designation from the Food and Drug Administration. The…
Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US
Lakefront Biotherapeutics' and Gilead Sciences' gamgertamig received orphan drug status from the US Food and Drug Administration for the additional treatment of a skin disorder called... Lakefront Biotherapeutics, Gilead Secure Another…
Total current assets of Lakefront Biotherapeutics – XETR:GXE
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic…
All Transcripts on Lakefront Biotherapeutics NV (LKFT)
Find all the latest transcripts on Lakefront Biotherapeutics NV Transcripts Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news and data tailored to specific country editions
Lakefront Biotherapeutics NV: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Lakefront Biotherapeutics NV on MarketScreener. Press Releases Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news and data tailored to…
Lakefront Biotherapeutics NV: News in other languages | LKFT | BE0003818359
Lakefront Biotherapeutics NV: News, information and stories for Lakefront Biotherapeutics NV | Euronext Amsterdam: LKFT | Euronext Amsterdam Other languages Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news…
Lakefront Biotherapeutics NV : Insider Transactions
Follow insider transactions on Lakefront Biotherapeutics NV in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Lakefront Biotherapeutics NV Biotechnology & Medical…
Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says
Lakefront Biotherapeutics has a meaningful opportunity with its asset gamgertamig for the treatment of rare autoimmune diseases, RBC Capital Markets said in a note Wednesday. Gamgertamig has... Biotechnology & Medical Research Lakefront…
Lakefront Biotherapeutics NV: Latest Headlines - Euronext Amsterdam Stock Exchange
Find the latest highlights on Lakefront Biotherapeutics NV at the Euronext Amsterdam stock exchange. Highlights Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news and data tailored to specific country editions
From articles in the 4Search news index.